Global and Japan Lung Cancer Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Immunoassays
  • 1.2.3 Flow Cytometry
  • 1.2.4 Rapid Tests
  • 1.2.5 Molecular Assays
  • 1.2.6 Tissue Arrays
  • 1.2.7 Circulating Tumor Cells
  • 1.2.8 Pharmacodiagnostics
  • 1.2.9 Biomarkers
  • 1.2.10 Other
• 1.3 Market by Application
  • 1.3.1 Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2026
  • 1.3.2 Industrial
  • 1.3.3 Healthcare
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Lung Cancer Diagnostics Market Perspective (2015-2026)
• 2.2 Global Lung Cancer Diagnostics Growth Trends by Regions
  • 2.2.1 Lung Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lung Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lung Cancer Diagnostics Players by Market Size
  • 3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue
• 3.4 Global Lung Cancer Diagnostics Market Concentration Ratio
  • 3.4.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2019
• 3.5 Key Players Lung Cancer Diagnostics Area Served
• 3.6 Key Players Lung Cancer Diagnostics Product Solution and Service
• 3.7 Date of Enter into Lung Cancer Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostics Breakdown Data by Type (2015-2026)

• 4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global Lung Cancer Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lung Cancer Diagnostics Market Size (2015-2026)
• 6.2 North America Lung Cancer Diagnostics Market Size by Type (2015-2020)
• 6.3 North America Lung Cancer Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Lung Cancer Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Lung Cancer Diagnostics Market Size (2015-2026)
• 7.2 Europe Lung Cancer Diagnostics Market Size by Type (2015-2020)
• 7.3 Europe Lung Cancer Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Lung Cancer Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Lung Cancer Diagnostics Market Size (2015-2026)
• 8.2 China Lung Cancer Diagnostics Market Size by Type (2015-2020)
• 8.3 China Lung Cancer Diagnostics Market Size by Application (2015-2020)
• 8.4 China Lung Cancer Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Lung Cancer Diagnostics Market Size (2015-2026)
• 9.2 Japan Lung Cancer Diagnostics Market Size by Type (2015-2020)
• 9.3 Japan Lung Cancer Diagnostics Market Size by Application (2015-2020)
• 9.4 Japan Lung Cancer Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Lung Cancer Diagnostics Market Size (2015-2026)
• 10.2 Southeast Asia Lung Cancer Diagnostics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Lung Cancer Diagnostics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Lung Cancer Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Roche Diagnostics
  • 11.1.1 Roche Diagnostics Company Details
  • 11.1.2 Roche Diagnostics Business Overview
  • 11.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
  • 11.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020))
  • 11.1.5 Roche Diagnostics Recent Development
• 11.2 BioMérieux
  • 11.2.1 BioMérieux Company Details
  • 11.2.2 BioMérieux Business Overview
  • 11.2.3 BioMérieux Lung Cancer Diagnostics Introduction
  • 11.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.2.5 BioMérieux Recent Development
• 11.3 Qiagen
  • 11.3.1 Qiagen Company Details
  • 11.3.2 Qiagen Business Overview
  • 11.3.3 Qiagen Lung Cancer Diagnostics Introduction
  • 11.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.3.5 Qiagen Recent Development
• 11.4 Advpharma
  • 11.4.1 Advpharma Company Details
  • 11.4.2 Advpharma Business Overview
  • 11.4.3 Advpharma Lung Cancer Diagnostics Introduction
  • 11.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.4.5 Advpharma Recent Development
• 11.5 AIT Austrian Institute of Technology
  • 11.5.1 AIT Austrian Institute of Technology Company Details
  • 11.5.2 AIT Austrian Institute of Technology Business Overview
  • 11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
  • 11.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.5.5 AIT Austrian Institute of Technology Recent Development
• 11.6 Courtagen Life Sciences
  • 11.6.1 Courtagen Life Sciences Company Details
  • 11.6.2 Courtagen Life Sciences Business Overview
  • 11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
  • 11.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.6.5 Courtagen Life Sciences Recent Development
• 11.7 DiagnoCure
  • 11.7.1 DiagnoCure Company Details
  • 11.7.2 DiagnoCure Business Overview
  • 11.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
  • 11.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.7.5 DiagnoCure Recent Development
• 11.8 BioMark Diagnostics
  • 11.8.1 BioMark Diagnostics Company Details
  • 11.8.2 BioMark Diagnostics Business Overview
  • 11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
  • 11.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.8.5 BioMark Diagnostics Recent Development
• 11.9 Mayo Clinic
  • 11.9.1 Mayo Clinic Company Details
  • 11.9.2 Mayo Clinic Business Overview
  • 11.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
  • 11.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.9.5 Mayo Clinic Recent Development
• 11.10 HalioDx SAS
  • 11.10.1 HalioDx SAS Company Details
  • 11.10.2 HalioDx SAS Business Overview
  • 11.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
  • 11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2015-2020)
  • 11.10.5 HalioDx SAS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer